Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Dec;75(12):2539-2540.
doi: 10.1002/acr.25177. Epub 2023 Aug 3.

Factors affecting serum urate monitoring among older adults with gout initiating urate-lowering therapy: comment on the article by Kwok et al

Kai-Lun Sheu  1 , Chun-Chieh Chen  1 , Shiuan-Chih Chen  1
Affiliations
Comment

Factors affecting serum urate monitoring among older adults with gout initiating urate-lowering therapy: comment on the article by Kwok et al

Kai-Lun Sheu et al. Arthritis Care Res (Hoboken). 2023 Dec.
No abstract available

PubMed Disclaimer

Comment in

  • Reply.
    Kwok TSH, Kuriya B, Hawker G, Choy G, Widdifield J. Kwok TSH, et al. Arthritis Care Res (Hoboken). 2023 Dec;75(12):2540. doi: 10.1002/acr.25188. Epub 2023 Aug 7. Arthritis Care Res (Hoboken). 2023. PMID: 37394725 No abstract available.

Comment on

References

    1. Kwok TS, Kuriya B, Hawker G, et al. Serum urate monitoring amongst older adults with gout initiating urate lowering therapy in Ontario, Canada. Arthritis Care Res (Hoboken) doi: https://doi.org/10.1002/acr.25167. 2023. E-pub ahead of print.
    1. Waldman B, Ansquer JC, Sullivan DR, et al. Effect of fenofibrate on uric acid and gout in type 2 diabetes: a post-hoc analysis of the randomised, controlled FIELD study. Lancet Diabetes Endocrinol 2018;6:310-8.
    1. Choi HK, Soriano LC, Zhang Y, et al. Antihypertensive drugs and risk of incident gout among patients with hypertension: population based case-control study. BMJ 2012;344:d8190.
    1. Juraschek SP, Simpson LM, Davis BR, et al. The effects of antihypertensive class on gout in older adults: secondary analysis of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. J Hypertens 2020;38:954-60.
    1. Zhou J, Liu X, Chou OH, et al. Lower risk of gout in sodium glucose cotransporter 2 (SGLT2) inhibitors versus dipeptidyl peptidase-4 (DPP4) inhibitors in type-2 diabetes. Rheumatology (Oxford) 2023;62:1501-10.

LinkOut - more resources